In colorectal cancer, METTL3 has been shown to have an oncogenic role by stabilizing HK2 and SLC1A2 mRNA via the IGF2BPs axis, regulating glycolytic metabolism and cell proliferation (22). This evidence concerns the gene SLC1A2 and colorectal cancer.